论文部分内容阅读
目的:探讨醒脑静治疗脑梗死的临床效果。方法:研究对象为2016年1月至2017年3月期间在我院接受脑梗死治疗的80例患者,随机分为研究组和对照组各40例,研究组患者使用醒脑静联合血栓通进行治疗,对照组患者使用血栓通进行治疗,观察两组患者的临床疗效。结果:治疗1周和2周后两组患者的神经功能评分明显降低,研究组患者经过治疗后病情改善情况显著优于对照组患者(P<0.05);研究组患者治疗后的总有效率为95.00%(38/40),明显高于对照组的80.00%(32/40),组间比较差异具有统计学意义(P<0.05)。结论:醒脑静能够有效改善脑梗死患者临床症状和患者神经功能,安全有效,可推广使用。
Objective: To investigate the clinical effect of Xingnaojing on cerebral infarction. Methods: The study included 80 patients who were treated with cerebral infarction in our hospital from January 2016 to March 2017 and were randomly divided into study group (40 cases) and control group (40 cases). The study group was treated with Xingnaojing combined with Xueshuantong Treatment, the control group of patients treated with thrombus, the clinical efficacy of two groups were observed. Results: After 1 week and 2 weeks, the scores of neurological function of the two groups were significantly decreased. The improvement of the patients in the study group was significantly better than that of the control group (P <0.05). The total effective rate of the study group was 95.00% (38/40), which was significantly higher than 80.00% (32/40) in the control group. The difference between the two groups was statistically significant (P <0.05). Conclusion: Xingnaojing can effectively improve the clinical symptoms of patients with cerebral infarction and patients with neurological function, safe and effective, and can be widely used.